• Janet Hays, founder of Healing Minds NOLA, is a formidable advocate for those who suffer from severe mental illness in New Orleans and across the country. She works tirelessly to bring those afflicted with mental illness, their families, and other stakeholders together to find a path to more productive and humane treatments of mental illness.

    Click on play to learn:

    Why someone who is mentally ill ends up being incarcerated instead of being admitted to a hospital for treatment. How anosognosia impairs a person’s ability to acknowledge their mental illness and subsequent refusal of treatment. What the vision is for assisted outpatient treatment (AOT).

    Janet Hays has been instrumental in New Orleans in shining a spotlight on the mismanaged mental health care system for more than six years. Having witnessed the inadequacies of mental health care in the United States, Hays has made it her life’s work to advocate for better ways to care for the mentally ill. Her vision includes residential treatment communities, assisted outpatient treatment, and even clubhouses to provide a venue for the mentally ill to reconnect to the community and make new friends.

    One of the issues that impedes medical treatment is anosognosia, a medical condition that impairs the ability of the individual recognize that they suffer from mental illness. They are unaware of their mental health condition, or they do not understand it correctly. The perception of their mental health can shift back and forth over time which adds to the belief that the person is denying the condition to avoid seeking treatment.

    One of the proposed plans for the treatment of mental illness is AOT, a community-based program of providing mental health treatment under civil court commitment. One of the objectives of the AOT program is to unite and encourage the mental health system in taking responsibility for collecting the necessary evidence of mental illness and prepare a petition for AOT to present to the court so the individual can receive the treatment they need.

    To learn more visit:



    Episode also available on Apple Podcast: http://apple.co/30PvU9C


  • Imagine feeling perfectly healthy and heading to your doctor for a simple cholesterol check, only to be told your blood work indicates that you may have an extremely rare, aggressive form of cancer. This is how most people are diagnosed with T-cell prolymphocytic leukemia (T-PLL).

    Dr. Marco Herling specializes in this type of cancer and shares his insights with listeners.

    Press play to learn:

    The difference between leukemia and lymphoma How the study of T-cell prolymphocytic leukemia (T-PLL) has led to a change in its name, and why it matters The most common physiological findings in patients who end up with a T-PLL diagnosis Why T-PLL is mostly a disease of the elderly, and the one exception

    Dr. Herling is an adjunct assistant professor in the Department of Hematopathology at the MD Anderson Cancer Center who was drawn to the study of T-PLL precisely because it is so rare and so understudied. In fact, he explains that most doctors struggle to diagnose it correctly and refer patients to the proper treatment. This lack of understanding exists even in large-volume academic centers and major university hospitals.

    In Western and European countries, the incidence of T-PLL is low, at about one to two cases per one million each year. “International networking is of the essence in order to make progress in this disease,” says Dr. Herling.

    He explains how T-PLL is generally diagnosed, the signs and symptoms of the disease, theories about why and how it develops, and possible ways to detect and eliminate it earlier on. He also talks about the current efforts being made to further the study and understanding of T-PLL, which hold promise for an eventual effective treatment.

    Interested in learning more?

    Tune in, and visit https://herlinglab.com/.

    Episode also available on Apple Podcast: http://apple.co/30PvU9C

  • Missing episodes?

    Click here to refresh the feed.

  • Is cancer its own separate organism? While we believe that it may not be most of the time, some instances of contagious cancer variants do not die with the host.

    Listen in to learn:

    How cancers may first arise Why metastatic sites hold vital clues to begin understanding metastasis How to backtrack a tumor to see how it may have formed

    Courtenay C. and Lucy Patten Davis Endowed Chair in Lung Cancer Research, James DeGregori, shares his expertise on various forms of cancer and the theoretical questions of the future.

    Many people think that random mutations may be the root cause of many forms of cancer. However, new research disputes this, and specialists have begun on a new research path of carcinogens and their effects on the body. While they may cause a higher rate of mutations in the area they affect, carcinogens seem to have many other impacts as well.

    The critical component of the speculation surrounding cancer is the "why?" of the developing tumors in specific areas that may not be favorable for it. By determining the traits present in particular cells where the tumor began, the genetics can be deciphered, providing a complete image of cancer's development.

    Visit degregori-lab for more information.

    Episode also available on Apple Podcasts: apple.co/30PvU9C

  • You may be familiar with cicadas but are you aware of the vast impact they have on the environment. A cicada emergence can leave lasting effects on the world around them. Press play to learn:

    What years cicadas emerge Why cicadas live most of their life underground What Samuel Ramsey plans on studying next

    Samuel Ramsey, founder and director of the Ramsey Research Foundation, joins the podcast to discuss his research regarding parasitic insects and the wondrous world of cicadas.

    While many refer to them as locusts, there is much that distinguishes cicadas, and they have a vast benefit on the world around them. Unlike what we may have previously believed, cicadas bring benefits that can have favorable effects on crops and the ecosystem they emerge in.

    From having a boon on growth and providing vast energy sources for animals across the ecosystem, the 13 and 17-year broods can have an incredible impact. By studying emergence patterns and the lifespans of cicadas, information can be gleaned on many natural systems.

    Search for Samuel Ramsey on Twitter at @drsammytweets

    Episode also available on Apple Podcasts: apple.co/30PvU9C

  • Dr. George Calin holds M.D. and Ph.D. degrees from Carol Davila University of Medicine in Bucharest, Romania. He completed cancer genomics training at the University of Ferrara in Italy and was a post-doctor fellow at the Kimmel Center in Pennsylvania. The focus of his work is exploring new RNA therapeutic options for cancer patients.

    Click on play to learn:

    Why research on non-coding RNAs is important and what makes them special. How studies of ultraconserved gene sequences led to the discovery of distinct signatures in human cancers. How combinatorial therapeutics for small RNAs shows promise in treating cancers.

    Dr. Calin is the Principal Investigator at the Calin Laboratory at MD Anderson. He is currently working on all aspects of molecular biology and biomarkers with a focus on deadly cancers such as ovarian, gastric, colon, pancreatic, and cholangiocarcinoma.

    It has become evident in recent cancer research that the genomic complexity of cancer cells is more significant than originally assumed. For more than 30 years, the focus was on the development and testing of new gene therapy strategies involving protein-coding genes. The research done by Dr. Calin and his colleagues has led to the concept that small non-coding RNAs knowns as microRNA genes (miRNAs) are involved in the production of human tumors. His research also showed that another family of ncRNAs, ultraconserved genes (UCGs) plays a role in cancer initiation, progression, and the mechanisms of a predisposition to cancer.

    Looking to the future, the results of the studies of miRNAs and ncRNAs has led to the possibilities of combinatorial therapeutics that are customized for a specific cancer patient. Dr. Calin believes that there is a strong need to focus on the early diagnosis of cancer which has the potential to increase the survival of cancer patients significantly.

    To learn more visit: mdanderson.org/research

    Episode also available on Apple Podcasts: apple.co/30PvU9C

  • Dr. Eliot Peyster is a heart transplant surgeon at the University of Pennsylvania Cardiovascular Institute. He is a member of the primary cardiology treatment team that specializes in cardiovascular conditions. In addition to heart transplant as a tool for treating end stage heart disease, Dr. Peyster is interested in the possibilities of using tissue samples from heart biopsies to study the heart at a microscopic level.

    Click on play to learn:

    What role inflammatory mediators plays in heart disease. How heart transplants and left ventricular assist devices are being used to treat people with severe heart disease. How computer vision analysis may be used to as a screening tool for high-risk heart disease in the future.

    Dr. Peyster describes coronary vascular disease as a leading cause of death, a disease of aging. Ischemic myopathy is generally understood regarding what causes heart blockages and how they relate to heart failure. However, too little is known about the role genetic and environmental factors play in the development of heart disease.

    Grading pathology slides from the biopsies of heart transplant patients has been somewhat problematic. A current concern is the grading criteria for tissue biopsies of the heart during the first year after a heart transplant. Rarely do the pathologists agree with each other when they assign a grade to this type of biopsy. The inconsistency of grading leads to confusion, making it more difficult to conduct multicenter research.

    Dr. Peyster and his colleagues have found a way to digitize the pathology slides. They have programmed a Computer-Assisted Cardiac Histologic Evaluation Grader to read the slides of the tissue samples from transplant patients to further study CMD. The hope is that a preventative approach can be developed to prevent small vessel disease

    To learn more visit: pennmedicine.org

    Episode also available on Apple Podcasts: apple.co/30PvU9C

  • What dictates your decision to buy one type of cereal over the other? Cost? Nutritional content? Or is something else…like the colors of the packaging, or the nostalgic association you have with it from childhood?

    The truth is, you might not even be consciously aware of why you make the product purchases you do. But rest assured…others are studying this topic very closely.

    Press play to learn:

    How to distinguish between and understand the deep drivers vs. random factors of decision-making How to bridge the disconnect between perceptual and mathematical models of probability in product purchase decisions Whether and how to use large amounts of unstructured data in decision-making processes

    Amit Gandhi is a professor at the University of Pennsylvania and applied economist at Microsoft, where he specializes in industrial organization and econometrics. In simpler terms, he focuses on the use of data in economic models and decision-making processes, whether at the organization, industry, or individual level.

    He explains the most common deep drivers of decision-making and their impact on behavioral outcomes, but draws special attention to the ‘random’ factors that impact decisions, but have no real connection to deep drivers like cost and utility. “Do you want to try to design choice architectures that make those things go away, or do you recognize them as part of the human condition and build your product strategy in such a way as to accommodate them?” asks Gandhi. Most of his current research is about answering this question.

    Tune in for all the details, and learn more about Gandhi’s work by finding him on Google Scholar.

    Episode also available on Apple Podcasts: apple.co/30PvU9C

  • How does understanding molecular evolution hold the key to significant advances in technology and preserving life? By studying it, there may even be clues to how to survive on planets other than Earth. Press play to learn:

    How synthesizing unnatural DNA building blocks is possible If we can test Martian geology to determine its base properties Why the "Vitamin C Gene" was integral to evolution

    A distinguished fellow and part of the Foundation for Applied Molecular Evolution, Steven Benner, discusses his research in molecular evolution and testing the viability of sustaining life on other planets.

    By understanding the basis of molecular DNA and its four natural bases, researchers can begin expanding that number to eight or even 12. This opens the possibility that various lifeforms may not have the same basis for evolution and developed using different mechanisms.

    By adapting to the world as the established systems were destroyed through phenomena like climate change, primates' DNA shifted and allowed the beings to evolve. This may be a similar trend to how humans will evolve to face future challenges.

    Visit https://primordialscoop.org to learn more.

    Episode also available on Apple Podcast: http://apple.co/30PvU9C

  • Nicholas (Nik) P. Money is a Professor and Director of the Western Program at Miami University. He has spent most of his professional career studying fungi and other microorganisms and has published several books on the topics. His new book, Nature Fast and Nature Slow, was released in the summer of 2021 and focuses on biology from a unique perspective, the timing of life.

    Click on play to learn:

    How miniscule units of time can be used to study fast mechanisms over slivers of time. Why Professor Money chose to focus his new book on the passing of time. What the prospects may be for human life extension.

    The subtitle of Nik Money’s new book is, “How Life Works, From Fractions of a Second to Billions of Years.” He captures the reader’s attention with thought provoking statements about how quickly time seems to pass, shares the concept of milliseconds, and discusses nature slow which stretches out over billions of years.

    The book explores the timetable of the universe in ten chapters with each chapter focusing on a particular slice of time beginning with nature fast. In the first chapter, Money discusses the evolution of nematocysts and expands on the evolution of the branches of the tree of life including sea slugs, anemones, comb jellies, and flatworms.

    Each chapter in the book opens a new world of information on evolutionary changes over time. The author discusses specific topics such as bowhead whales, bats, and bristlecones. He is already planting the seeds of a new book that focuses on nature big and small.

    To learn more visit: https://themycologist.com

    Episode also available on Apple Podcast: http://apple.co/30PvU9C

  • Is someone pulling the wool over the country's eyes when it comes to the pros and cons of the inoculation? Informed consent is an important right to retain and may be the key to safely inoculating the population.

    Press play to learn:

    The number of inoculation suggested by the CDC How inoculation may have been shown to correlate with adverse side affects The social groups which are responsible for inoculation pressure

    Health freedom lawyer Greg Glaser shares his experience fighting for informed consent for a large population of civilians and doctors around the country, especially in the age of high-pressure inoculation.

    Inoculation have been an integral part of American society since the latter decades of the 1900s, regardless of whether they actually make people healthier. Unfortunately, due to the social pressure cultivated by years of high-profit marketing from the inoculation industry, the truth may not correlate with the information widely pushed in the media.

    The social constructs that have held inoculation status in paramount status for years now are also the same that cause the alienation and ridicule imposed by the inoculated population. However, this is reaching a fever pitch as mandatory inoculation have become increasingly popular among some political parties.

    Visit informedconsentdefense.org to learn more.

    Episode also available on Apple Podcasts: apple.co/30PvU9C

  • Dr. Abdul Kadir Slocum is a co-founder of Chemothermia, an oncology center in Turkey that combines conventional cancer treatments with “out-of-the-box” therapies to improve cancer treatment outcomes. Dr. Slocum began the clinic in 2010 in Turkey with two partners, Professor Bulent Berkarda, M.D., and Professor Mehmet Salih İyikesici, M.D. to treat cancer patients from around the world.

    Click on play to learn:

    What role cellular metabolism has in health. How diet, hyperthermia, and hyperbaric oxygen therapy maximise the efficacy and reduce the side effects of conventional treatments. How holistic treatments support the patient undergoing traditional cancer treatments with promising results.

    Dr. Slocum has been working with Dr. İyikesici and Dr. Berkarda on the development and application of conventional and unconventional cancer treatments such as oxygen therapy for cancer to support and balance the system. These supportive treatments give the patient more time to fight the disease.

    Therapies include metabolically supported chemotherapy, hyperthermia (local and whole body) therapy, hyperbaric oxygen therapy, and the ketogenic diet that all work synergistically with the standard conventional cancer treatments. Integrating the genetic and metabolic approaches with supportive strategies can maximise the efficacy of conventional treatments and reduce their side effects.

    Chemothermia claims to have one of the highest success rates in the world with their unique approach on cancer treatment. The clinic publishes their results in leading peer reviewed journals. Patients with stage 3 and stage 4 cancers can be treated at the clinic. Doctors develop personalized protocols for each patient treated at the clinic with promising results.

    To learn more visit: chemothermia.com

    Episode also available on Apple Podcasts: apple.co/30PvU9C

  • “This is one of the biggest stories ever,” says T. Colin Campbell.

    What story is he talking about?

    The one that offers clear evidence of a safe, natural, and effective way to reverse cancer, diabetes, heart disease, and more.

    Tune in to discover:

    Whether there is a difference between the protein from pasture-fed animals and feedlot animals How taste preferences can change powerfully over a relatively short period of time Hidden sources of animal protein that you may not even know you consume Why most vegans still develop some of the same diseases as non-vegans and non-vegetarians

    T. Colin Campbell grew up on a farm, which meant growing up on dairy and animal meat. His doctoral dissertation was on the importance of animal protein consumption, and he even led a program in the Philippines aimed at helping malnourished children by providing them with quality animal proteins.

    His belief was firm, and in line with the rest of the nutritional science community: malnourishment results from inadequate amounts of quality protein from animal sources.

    But in reality, he encountered evidence which completely challenged this position: the Filipino children who were consuming animal protein like those in the Western world were at a higher risk of developing liver cancer. Animal studies showed the same thing: animals who consumed animal protein were more susceptible to the rapid growth of liver cancer.

    Campbell was faced with a dilemma: would he move forward with all the work he’d already promoted, or back up and carefully re-examine the evidence? He chose the latter, and received plenty of NIH funding to study whether animal protein really does cause cancer.

    The answer? An emphatic “Yes,” says Campbell. He has since published extensively on the topic and even served on government policy boards.

    “The further I got into this story and learned so much about it—not just about animal protein itself but also about the entire medical system and the way we actually tell the public the information we tell them—the more I realized there’s a serious problem here,” says Campbell.

    Heart disease, diabetes, and cancer are just a few of the diseases that can be treated and altogether reversed through a whole foods, plant-based diet.

    Interested in learning more?

    Press play, and visit https://nutritionstudies.org/.

    Episode also available on Apple Podcasts: apple.co/30PvU9C

  • Magic mushrooms have long been associated with 60s Counterculture—hippies dancing to the tune of free love, out of their minds on psychedelic drugs.

    In reality, mushrooms were used by ancient cultures for a variety of medicinal and health reasons, but are only recently being recognized once again as a legitimate substance for boosting brain health.

    Tune in to discover:

    Which areas of the brain are affected by functional versus psychedelic mushrooms What mycelium is, and how to grow it without excess starch or other unwanted fillers How microdosing works, how it differs from consuming with the intention to get “high”, and why it’s difficult to build tolerance to psychedelic mushrooms

    Chris Claussen is the co-founder and chief of product at Leiio Wellness, and Christian Kaelin is a senior mycologist and product manager at the same company. They both join the show to share with listeners the amazing potential of functional and psychedelic mushrooms as they relate to brain health, neurogenesis, and potentially even a treatment for Alzheimer’s disease.

    “It’s an ancient medicine that was taken away from us through making it illegal, and now there are a lot of measures to reintroduce it as a healthy part of our lives,” says Claussen.

    At Leiio, the focus is on the use of mushrooms for brain performance, including the expansion of awareness and consciousness, enhanced focus, and greater creativity. While eagerly awaiting the legalization of psychedelic mushrooms, they are tending to a fully operational farm for functional mushrooms, and will also be producing a line of nutraceuticals designed to target neurotransmitters for specific purposes.

    They discuss how each of their products work, what they are best used for, and how to get them.

    Press play to hear the full conversation and visit https://www.leiiowellness.com/ to learn more.

    Episode also available on Apple Podcasts: apple.co/30PvU9C

  • How can early detection and regular monitoring of breast health play a significant role in the severity of breast cancer? The earlier cancer can be detected, a significant possibility emerges that an early understanding can benefit the patient when treatment begins. Listen in to learn:

    How heterogeneity impacts various tumors If chemotherapy is contributing to tumors in specific ways How early-stage testing can save lives

    Professor of Medicine at Harvard Medical School and member of the Dana-Farber Cancer Institute, Kornelia Polyak, shares her research on the monitoring and preventing breast cancer.

    Through understanding why and when an individual gets breast cancer, better treatment techniques may become available, and prevention methods can be uncovered. In addition, through a deeper understanding of cause and early behavior, the next stages of treatment and prevention research can progress.

    The location of tumors and the environment within the body can play a significant part in determining the heterogeneity of cancer. This level of heterogeneity is one of the defining characteristics of how to treat and prevent tumors.

    For more information, visit polyaklab.dfci.harvard.edu.

    Episode also available on Apple Podcasts: apple.co/30PvU9C

  • Finally, you can take a deep breath in and relax…knowing you’ve also taken the lowest efficacious dose of your medicine, with less worry over adverse events. And it’s all thanks to a company called TFF Pharmaceuticals.

    Press play to learn:

    What specific problem TFF technology solves in terms of drug metabolism and systemic absorption How TFF technology can be applied to the area of vaccines Whether TFF technology could be used with cannabinoids as an alternative to vaping

    Glenn Mattes has worked in the pharmaceutical industry for over forty years now, and for the past four years, has served as CEO of TFF Pharmaceuticals, a Thin Film Freezing technology platform that can improve the properties of drug formulation, delivery, and administration while maintaining efficacy and avoiding many adverse events associated with other drug therapies.

    The Thin Film Freezing technology uses flash freezing to capture pharmaceutical drugs in a highly active state and convert them into highly concentrated powders. These powders can then be put into a capsule and inhaler device, allowing for administration directly into the lungs. Since the lung is an ideal organ for drug metabolism and distribution throughout the body, lower doses of the drug can be used to achieve the same or better efficacy with lower incidence of adverse events.

    Other substances being formulated at TFF Pharmaceuticals can be inhaled through the nose, and in the works is a formulation that can be applied to the eyes or skin.

    Mattes explains the science behind this technique, including the details of how and why it works, and the specific ways in which it can be applied.

    Learn more at https://tffpharma.com/.

    Episode also available on Apple Podcast: http://apple.co/30PvU9C

  • “When psychiatry became wedded with the drug companies, it became very little more than a sales department of the pharmaceutical industry,” says Dr. Peter Breggin.

    He explains the pre-wedding state, post-wedding state, the future of psychiatry, and how it’s all related to the current virus situation.

    Tune in to discover:

    What a lobotomy is, how it works, and how recently it’s been performed in the US Why various competing views in psychiatry have been reduced to one predominant viewpoint (and what that viewpoint is) The damaging side effects and deaths related to the vaccine for the current virus

    Dr. Breggin is a psychiatrist and author of over 20 books, with one of his most recent publications addressing the current virus situation and the influence of global predators.

    He’s been involved with reform work his whole life, starting with giant volunteer projects in state mental hospitals over 60 years ago, to taking on almost all major lobotomy programs in the US since then, and to this very day, trying to tackle electroshock therapy, and what he calls “chemical lobotomies” through psychiatric drugs.

    Dr. Breggin is the first psychiatrist to take various issues to the courtroom, and has been in trial over 100 times. Along the way, he’s been attacked and slandered by scientists, clinicians, fellow psychiatrists, and the medical-scientific establishment at large, but nonetheless remains firm in his stance against what he perceives to be unethical and even violent practices aimed at controlling humanity.

    In today’s show, he reveals these practices in detail and explains how they are intimately tied to the current virus situation.

    Tune in to hear the full conversation. Visit www.wearetheprey.com to check out his latest book and learn more.

    Episode also available on Apple Podcasts: apple.co/30PvU9C

  • “All malignant diseases are derived from a normal cell in the body,” says Dr. Owen O’Connor, MD, PhD. But how different are the malignant cells from the normal ones, and how hard is it to differentiate one from the other?

    This question is at the heart of the 'therapeutic window' problem in cancer treatment. But with new research in full swing, a solution may be within reach.

    Press play to learn:

    The four eras of cancer treatment, and where the future of cancer therapy is headed The problem of the therapeutic window and modern-day chemotherapies, and how a combination of immunotherapy and precision medicine could overcome it The function of B cells in the body; how they behave differently in malignant disease vs. autoimmune disease

    Dr. O’Connor is an international authority on lymphoma and drug development with over 25 years of experience in academic medicine. He is also Chief Scientific Officer at TG Therapeutics, a biotechnology company that focuses on targeting diseases related to underlying B cell dysfunction, like non-Hodgkin’s lymphoma and some autoimmune diseases.

    B cells are a type of white blood cell that produce antibodies designed to rid the body of pathogens. In lymphoma and some autoimmune diseases, however, these normal B cells begin wildly misbehaving or proliferating rapidly. In the case of malignant disease, the goal is to inhibit the proliferation of and kill these B cells; in the case of autoimmune disease, the goal is to suppress their activity and interactions with other cells in the body.

    How is this accomplished? And what’s wrong with most modern chemotherapies?

    Answering these questions leads Dr. O’Connor to discuss the meaning of the therapeutic window and two drugs that have been acquired and studied extensively by the team at TG Therapeutics. One of these drugs is an immunotherapy, and the other is a precision targeted therapy. The idea is that working together, these drugs could provide an effective treatment without the serious downsides of chemotherapies.

    Visit https://www.tgtherapeutics.com/ to learn more.

    Episode also available on Apple Podcasts: apple.co/30PvU9C

  • Kiana Aran, Ph.D. is an associate professor and director of the Aran Lab at Keck Institute and is also the Chief Scientific Officer at Cardea Bio. She is an electrical engineer with a driving interest in biology that has led her to combining these two seemingly unconnected fields. Her research has led to the discovery that amplification is not required for targeted DNA and gene detection.

    Click on play to learn:

    How functionalizing materials can be used in biosensing technologies and in lab-on-a-chip (LOC) systems. How linking biology directly with electronics molecular control signals can be accessed and studied. How the first DNA search engine is possible using a CRISPR-SNP-chip and graphene.

    Dr. Aran is interested in the integration electrical, mechanical, chemical, and bioengineering to develop new device solutions for use in clinical research. She thinks of the CRISPR chip as a microscopic robot that can be used as a genome typing tool, a kind of DNA search engine. This tool provides the ability to search through a complete genome in record time, among other things.

    Currently, the sensitivity of the platform is being evaluated and improved to allow for more types of research. Work is currently being conducted to assess the accuracy and efficiency of CRISPR itself. Research continues on combining the power of CRISPR in its search capabilities and the power of biology as a technology to facilitate research and new discoveries.

    To learn more visit: aranlab.org and cardeabio.com

    Episode also available on Apple Podcasts: apple.co/30PvU9C

  • A cure for cancer? Immunotherapy could be the key.

    Tune in to discover:

    How an antiviral response is similar to an anti-tumor response The various ways in which cancer evades the immune system Which immunotherapies can treat end-stage patients, and how they work

    Samantha Bucktrout is the senior director of research at Parker Institute for Cancer Immunotherapy, where she focuses on bringing curative immunotherapy for patients with cancer.

    She begins by explaining the basics of immunotherapy, noting that all throughout each and every day, our immune systems are at work detecting and eliminating pre-cancerous cells in the body.

    For patients who have developed metastasis and where the standard of care has failed, immunotherapy might provide promise. Research in immunology has led to an understanding of the ways in which cancer co-opts the body’s natural ability to regulate the immune system, and thereby actively blocks it from doing its job. Equipped with this knowledge, it’s possible to block the barriers put up by cancer through the use of antibodies.

    Immunotherapy, in some cases, can be considered to ‘cure’ patients who otherwise have fatal metastatic processes.

    Bucktrout discusses how chemotherapy affects the immune response, when it is used as the sole approach to cancer treatment as opposed to in conjunction with chemotherapy, how cancer cells may have evolved to evade the immune response, and much more.

    Press play to hear the full conversation and learn more at https://www.parkerici.org/.

    Episode also available on Apple Podcasts: apple.co/30PvU9C

  • “If you can’t sleep, so what?” asks Annie Miller.

    Well, you may or may not agree, but the point she’s making is that it’s far better to not care about a lack of sleep than to panic about it.

    Press play for more of her insights and learn:

    How different people are responding differently to the virus-related shutdowns and re-entry into the “old” way of life Why the bed should only be for sleeping Why eight hours of sleep isn’t best for everyone

    Annie Miller is a psychotherapist and the founder of DC Metro Sleep and Psychotherapy, a private practice in Bethesda, Maryland. Her specialties include sleep and insomnia, anxiety, trauma, and chronic pain.

    In today’s show, she discusses how the current virus situation has been impacting people’s anxiety and sleep health, and also explains her approach to helping people through these issues. In the process, she provides several tips on establishing and maintaining good sleep hygiene.

    Tune in for all the details and visit https://dcmetrotherapy.com/ to learn more.

    Episode also available on Apple Podcasts: apple.co/30PvU9C